ISL
SNY icon

Ingalls & Snyder LLC’s Sanofi SNY Stock Holding History

Ingalls & Snyder LLC’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$734K Buy
15,240
+125
+0.8% +$5.83K 0.03% 242
2025
Q4 		$732K Sell
15,115
-750
-5% -$37.2K 0.03% 247
2025
Q3 		$749K Sell
15,865
-80
-0.5% -$3.86K 0.02% 254
2025
Q2 		$770K Hold
15,945
– – 0.03% 249
2025
Q1 		$884K Sell
15,945
-500
-3% -$27.1K 0.03% 236
2024
Q4 		$793K Sell
16,445
-400
-2% -$20.3K 0.03% 237
2024
Q3 		$971K Hold
16,845
– – 0.04% 226
2024
Q2 		$817K Hold
16,845
– – 0.04% 237
2024
Q1 		$819K Hold
16,845
– – 0.04% 240
2023
Q4 		$838K Sell
16,845
-450
-3% -$22K 0.04% 228
2023
Q3 		$928K Buy
17,295
+200
+1% +$10.7K 0.04% 215
2023
Q2 		$921K Sell
17,095
-400
-2% -$21.5K 0.04% 225
2023
Q1 		$952K Sell
17,495
-475
-3% -$23.1K 0.05% 216
2022
Q4 		$870K Buy
17,970
+6,445
+56% +$283K 0.05% 216
2022
Q3 		$438K Sell
11,525
-600
-5% -$26.7K 0.02% 287
2022
Q2 		$607K Buy
12,125
+3,580
+42% +$190K 0.03% 263
2022
Q1 		$439K Sell
8,545
-840
-9% -$43.4K 0.02% 319
2021
Q4 		$470K Buy
9,385
+740
+9% +$36.6K 0.02% 315
2021
Q3 		$417K Sell
8,645
-700
-7% -$35.6K 0.02% 334
2021
Q2 		$492K Buy
9,345
+200
+2% +$10.4K 0.02% 317
2021
Q1 		$452K Sell
9,145
-200
-2% -$9.61K 0.02% 307
2020
Q4 		$454K Buy
9,345
+575
+7% +$28.4K 0.02% 299
2020
Q3 		$440K Hold
8,770
– – 0.03% 255
2020
Q2 		$448K Sell
8,770
-200
-2% -$9.72K 0.03% 270
2020
Q1 		$392K Hold
8,970
– – 0.03% 286
2019
Q4 		$450K Buy
8,970
+2,441
+37% +$114K 0.02% 278
2019
Q3 		$302K Sell
6,529
-585
-8% -$25.2K 0.01% 343
2019
Q2 		$308K Sell
7,114
-701
-9% -$29.8K 0.01% 345
2019
Q1 		$346K Hold
7,815
– – 0.02% 327
2018
Q4 		$339K Hold
7,815
– – 0.02% 318
2018
Q3 		$349K Sell
7,815
-400
-5% -$17.1K 0.01% 340
2018
Q2 		$329K Sell
8,215
-349
-4% -$13.7K 0.02% 322
2018
Q1 		$343K Buy
8,564
+750
+10% +$31.2K 0.02% 305
2017
Q4 		$336K Buy
7,814
+104
+1% +$4.8K 0.02% 312
2017
Q3 		$384K Buy
7,710
+5
+0.1% +$242 0.02% 268
2017
Q2 		$369K Hold
7,705
– – 0.02% 270
2017
Q1 		$349K Hold
7,705
– – 0.02% 295
2016
Q4 		$312K Sell
7,705
-1,530
-17% -$60.3K 0.02% 308
2016
Q3 		$353K Hold
9,235
– – 0.02% 288
2016
Q2 		$386K Sell
9,235
-683
-7% -$28K 0.02% 289
2016
Q1 		$398K Sell
9,918
-56
-0.6% -$2.25K 0.03% 246
2015
Q4 		$425K Sell
9,974
-289
-3% -$13.3K 0.03% 244
2015
Q3 		$487K Sell
10,263
-122
-1% -$6.21K 0.03% 231
2015
Q2 		$514K Sell
10,385
-400
-4% -$20.3K 0.03% 234
2015
Q1 		$533K Sell
10,785
-645
-6% -$30.8K 0.03% 230
2014
Q4 		$521K Sell
11,430
-42,026
-79% -$2.04M 0.03% 235
2014
Q3 		$3.02M Buy
53,456
+530
+1% +$28.5K 0.16% 98
2014
Q2 		$2.81M Sell
52,926
-893
-2% -$47.4K 0.14% 106
2014
Q1 		$2.81M Buy
53,819
+210
+0.4% +$10.6K 0.15% 104
2013
Q4 		$2.88M Buy
53,609
+36,400
+212% +$1.88M 0.16% 104
2013
Q3 		$871K Hold
17,209
– – 0.05% 182
2013
Q2 		$886K Buy
+17,209
New +$917K 0.06% 185

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Ingalls & Snyder LLC's SNY Position: Q1 2026 in Review

Ingalls & Snyder LLC increased its Sanofi (SNY) stake by 0.83% in Q1 2026, buying an estimated $5.83K and bringing the position to 15,240 shares worth $734K. The position accounts for 0.03% of the portfolio, ranked #242.

Ingalls & Snyder LLC first reported a position in SNY in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.02M in Q3 2014. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Ingalls & Snyder LLC held 15,240 shares of Sanofi worth $734K as of Q1 2026.
  • Ingalls & Snyder LLC bought 125 Sanofi shares in Q1 2026, an estimated $5.83K.
  • Sanofi made up 0.03% of Ingalls & Snyder LLC's portfolio in Q1 2026, its #242 holding.
  • Ingalls & Snyder LLC first reported a position in Sanofi in Q2 2013 and has held it in 52 quarters since.
  • Ingalls & Snyder LLC's Sanofi position peaked at $3.02M in Q3 2014.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Ingalls & Snyder LLC's 13F filing for Q1 2026, filed 13 May 2026.